Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: A new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay

Medical Mycology

Volumn 49, Issue 8, 2011, Pages 883-886

  Morio, Florent ^a,b   Fraissinet, François ^a   Gastinne, Thomas ^c   Pape, Patrice Le ^a,b   Delaunay, Jacques ^c   Sigler, Lynne ^d   Gibas, Connie Fe C ^d   Miegeville, Michel ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cross reactivity; Galactomannan antigen assay; Haematological malignancy; Invasive aspergillosis; Myceliophthora thermophila

Indexed keywords

ANTIINFECTIVE AGENT; CASPOFUNGIN; CYTARABINE; DAUNORUBICIN; GALACTOMANNAN; GEMTUZUMAB OZOGAMICIN; MITOXANTRONE; VORICONAZOLE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROSS REACTION; DRUG WITHDRAWAL; DYSPLASIA; DYSPNEA; FEVER; FUNGUS; HEMOPTYSIS; HUMAN; IMMUNOASSAY; KARYOTYPE; LEUKOCYTOSIS; LOADING DRUG DOSE; LUNG LAVAGE; LUNG LOBE; LUNG NODULE; MALE; MYCELIOPHTHORA THERMOPHILA; MYCOSIS; NEUTROPENIA; NONHUMAN; THORAX PAIN;

ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BASE SEQUENCE; CROSS REACTIONS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MANNANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOSES; NEUTROPENIA; PYRIMIDINES; SENSITIVITY AND SPECIFICITY; SORDARIALES; SPORES, FUNGAL; TRIAZOLES;

ASPERGILLUS GALACTOMANNAN; CORYNASCUS HETEROTHALLICUS;

EID: 80054714289     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.584218     Document Type: Article

References (16)

1. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349-357. (Pubitemid 38692699)
2. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised def nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
3. Giacchino M, Chiapello N, Bezzio S, et al. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J Clin Microbiol 2006; 44: 3432-3434. (Pubitemid 44413798)
4. Fekkar A, Brun S, D'Ussel M, et al. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis 2009; 49: 1457-1458.
5. Xavier MO, Pasqualotto AC, Cardoso IC, Severo LC. Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryp-tococcus species in the commercial Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 2009; 16: 132-133.
6. Pineau S, Talarmin JP, Morio F, et al. Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis. Med Mal Infect 2010; 40: 541-543. [in French].
7. Wheat LJ, Hackett E, Durkin M, et al. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immu-noassay. Clin Vaccine Immunol 2007; 14: 638-640.
8. Cummings JR, Jamison GR, Boudreaux JW, et al. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007; 59: 113-115. (Pubitemid 47391183)
9. Borrás R, Roselló P, Chilet M, et al. Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage f uid from a patient with an invasive infection due to Lichtheimia ramosa. J Clin Microbiol 2010; 48: 3035-3036.
10. Rodriguez-Tudela JL, Arendrup MC, Arikan S, et al. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008; 14: 982-984.
11. De Hoog GS, Guarro J, Gen é J, Figueras MJ (Eds). Atlas of Clinical Fungi, 2nd ed. Utrecht, The Netherlands and the Rovira I Virgili University, Reus, Spain: Centraalbureau voor Schimmelcultures, 2000.
12. Bourbeau P, McGough DA, Fraser H, Shah N, Rinaldi MG. Fatal disseminated infection caused by Myceliophthora thermophila, a new agent of mycosis: case history and laboratory characteristics. J Clin Microbiol 1992; 30: 3019-3023.
13. Destino L, Sutton DA, Helon AL, et al. Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury. Ann Clin Microbiol Antimicrob 2006; 5: 21.
14. Farina C, Gamba A, Tambini R, Beguin H, Trouillet JL. Fatal aortic Myceliophthora thermophila infection in a patient affected by cystic medial necrosis. Med Mycol 1998; 36: 113-118.
15. Tekkok IH, Higgins MJ, Ventureyra EC. Posttraumatic gas-containing brain abscess caused by Clostridium perfringens with unique simultaneous fungal suppuration by Myceliophthora ther-mophila: case report. Neurosurgery 1996; 39: 1247-1251. (Pubitemid 26386803)
16. Weitzel N, Puskas F, Cleveland J, Levi ME, Seres T. Left ventricular assist device outf ow cannula obstruction by the rare environmental fungus Myceliophthora thermophila. Anesth Analg 2009; 108: 73-75.